Clinical Newsletter
Regular updates on our latest clinical studies.
Our research and development teams operate at a global level and generate synergies from our collective expertise and by drawing on related disciplines. We are also constantly exchanging information at an international level with independent technical institutions, key opinion leaders and multipliers in order to be able to ensure cooperation and knowledge management of the highest order. As part of this process, we also conduct extensive research, the results of which we continually present in workshops, at conferences and symposiums - either in documentation or talks given by our cooperation partners - and also publish in renowned scientific journals. This database contains a large number of these evidence-based scientific articles, most of which have been evaluated by independent assessors:
Aim:
To compare the efficacy of 2 products in managing slough and hyperkeratosis. Outcome measures included visible effect, treatment time, patient and clinician feedback.
Method:
Patients with lower limb wounds and hyperkeratosis were treated in a wound clinic with either a debridement pad or a debridement cloth. Outcomes were recorded over 3-weeks. Continuing treatment plans were documented at week 4.
Results / Discussion:
Using the debridement pad clinicians noted an immediate removal of slough/hyperkeratosis along with a ’deep clean’ effect in all cases. Clinicians felt a smaller option would be useful for some wounds. Clinicians remarked on a ’film’ or ’froth’ left in the wound/limb with the debridement cloth. A difficulty with getting into deeper areas of the wound was also noted. 1 patient did express willingness to continue with the product and reported ease of use. In response to the initial results, clinical evidence and NICE guidance, the decision was made to stop the evaluation and include debridement pads on the woundcare formularly.
Conclusion:
Whilst there was some improvement reported with the use of a debridement cloth, there was a visible imporvement for all cases with the debridement pad. This has led to improved patient satisfaction, influenced clinical practice and formulary inclusion.
Aim:
To report positive outcomes from the management of a complex case of chronic oedema. Highlighting the importance of biofilm management and specialist bandage techniques.
Method:
Upon assessment, the patient had received compression therapy for over 15 years. Daily bandage reapplication had been ongoing for 3 years. Pain score upon assessment 10/10.
Results / Discussion:
This approach has involved partnership from a varied skill mix within the team, including healthcare assistants and tissue viability specialists. This and the reduction of visits has enabled cost minimisation and improved clinical outcomes. The patient’s has an increased self-esteem and feels able to now interact socially, improving her quality of life.
Conclusion:
Chronic oedema management invoving a partnership approach, utilising skin-care and specialist bandage techniques can improve clinical outcomes, reduce costs and improve quality of life.